ArticleJournal of hematology & oncology2013

Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity.

Laura Quotti Tubi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.